Fifth Third Bancorp’s Day One Biopharmaceuticals DAWN Stock Holding History

Fifth Third Bancorp’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-774	Closed	-$16.6K	–	4370
2026 Q1	$16.6K	Buy	+774	New	+$10.9K	﹤0.01%	3555

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fifth Third Bancorp's DAWN Position: Q2 2026 in Review

Fifth Third Bancorp sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 774 shares — an estimated $16.6K sold.

Fifth Third Bancorp first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $16.6K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Fifth Third Bancorp reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Fifth Third Bancorp sold 774 Day One Biopharmaceuticals shares in Q2 2026, an estimated $16.6K.
Fifth Third Bancorp first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Fifth Third Bancorp's Day One Biopharmaceuticals position peaked at $16.6K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.